Inventor
Richard J. Bucala
Inventor
New York, NY, US
Overview
Patents· 56 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12NMicroorganisms or enzymes10%
C12YEnzymes4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
Y02ATechnologies for adaptation to climate change4%
A01KAnimal husbandry3%
C07DHeterocyclic compounds3%
PatentTitleYear
10,842,859Uses of parasite macrophage migration inhibitory factors202010,765,739Use of MIF and MIF pathway agonists202010,202,343MIF modulators20199,643,922'MIF modulators'20179,540,322'MIF modulators'20179,308,255'Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury'20169,221,903'Method of inhibiting binding or activity of MIF by administering a MIF antagonist'20159,139,877'Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease'20158,779,099'MIF antagonists'20148,617,822'Method of inhibiting binding or activity of MIF by administering a MIF antagonist'20137,745,121'Polymorphism in the macrophage migration inhibitory factor (MIF) gene as marker for prostate cancer'20107,741,057'Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor'20107,517,523'Anti-MIF antibodies'20097,205,107'Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory disease'20076,998,238'Method for determining MIF content'20066,774,227'Therapeutic uses of factors which inhibit or neutralize MIF activity'20046,759,036'Fibrocyte-base vaccine formulations'20046,645,493'Composition containing anti-MIF antibody'20036,599,938'Compounds having MIF antagonist activity'20036,596,851'Inducible phosphofructokinase and the Warburg effect'20036,492,428'Compounds having MIF antagonist activity'20026,420,188'Screening assay for the identification of inhibitors for macrophage migration inhibitory factor'20026,413,939'Inducible phosphofructokinase and the Warburg effect'20026,410,598'Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis'20026,391,899'Compounds and compositions for treating tissue ischemia'20026,380,165'Immunological advanced glycation endproduct crosslink'20026,255,046'Inducible phosphofructokinase and the warburg effect'20016,174,526'Blood-borne mesenchymal cells'20016,110,968'Methods for treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts'20006,080,407'Diagnostic assays for MIF'20006,054,121'Modulation of immune responses in blood-borne mesenchymal cells'20006,030,615'Combination method for treating diseases caused by cytokine-mediated toxicity'20006,025,401'Method and agents for inhibiting protein aging'20005,935,927'Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts'19995,921,248'Tobacco combination product filter'19995,869,534'Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom'19995,854,000'Methods for measurement predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts'19985,850,840'Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts'19985,849,307'Vaccine adjuvant'19985,846,796'Blood-borne mesenchymal cells'19985,811,401'Advanced glycosylation endproducts and methods of use therefor'19985,804,446'Blood-borne mesenchymal cells'19985,801,200'Methods and materials for the diagnosis and treatment of conditions such as stroke'19985,780,615'Glycosylation of lipids and lipid-containing particles and diagnostic and therapeutic methods and materials derived therefrom'19985,770,571'Method and agents for inhibiting protein aging'19985,733,524'Methods and materials for the diagnosis and treatment of conditions such as stroke'19985,733,546'Immunochemical detection of in vivo advanced glycosylation endproducts'19985,733,933'Methods and materials for the diagnosis and treatment of conditions such as stroke'19985,712,101'Immunochemical detection of in vivo advanced glycosylation endproducts'19985,702,704'Antibodies to in vivo advanced glycosylation endproducts'19975,700,447'Methods and materials for the diagnosis and treatment of conditions such as stroke'19975,683,887'Immunochemical detection of in vivo advanced glycosylation endproducts'19975,654,186'Blood-borne mesenchymal cells'19975,629,408'Immunochemical isolation of in vivo advanced glycosylation endproducts'19975,624,804'Immunochemical detection of In vivo advanced glycosylation end products'19975,610,076'Method for detecting hemoglobin advanced glycosylation endproducts'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2004Patents assigned to PICOWER INST MED RES (30)· patent assignee history
1997–1998Patents assigned to UNIV ROCKEFELLER (6)· patent assignee history
1997–2006Based in New York, NY, US· patent location history
1998–2019Based in Cos Cob, CT, US· patent location history
2004–2010Patents assigned to CYTOKINE PHARMASCIENCES INC (5)· patent assignee history
2013–2017Patents assigned to BUCALA RICHARD J (5)· patent assignee history
2016–2020Patents assigned to UNIV YALE (6)· patent assignee history
2020Based in New Haven, CT, US· patent location history
2020Based in Greenwich, CT, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PICOWER INST MED RES | 30 | 1997–2004 |
| UNIV ROCKEFELLER | 6 | 1997–1998 |
| UNIV YALE | 6 | 2016–2020 |
| BUCALA RICHARD Jself | 5 | 2013–2017 |
| CYTOKINE PHARMASCIENCES INC | 5 | 2004–2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 28 | 1997–2006 |
| Cos Cob, CT, US | 26 | 1998–2019 |
| New Haven, CT, US | 1 | 2020 |
| Greenwich, CT, US | 1 | 2020 |